APHERESIS OF A TARGET MOLECULE FROM CEREBROSPINAL FLUID

• US 20100030196A1
• Filed: 07/29/2009
• Published: 02/04/2010
• Est. Priority Date: 07/29/2008
• Status: Abandoned Application

• Current Assignee: Medtronic Incorporated (Medtronic Plc)
• Original Assignee: Medtronic Incorporated (Medtronic Plc)
• Inventors: Hildebrand, Keith, Shafer, Lisa Lynn, Thakker, Deepak Ramesh
• Application Number:
  US12/511,571
• Publication Number:
  US 20100030196A1
• Time in Patent Office: Days
• US Class Current: 604/540
• CPC Class Codes: A61M 27/006 Cerebrospinal drainage; Accessories therefor, e.g. valves

Abstract

A system includes (i) a medium having a solid support to which an antibody directed to target molecule is bound, (ii) a reservoir for containing the medium, (iii) a first catheter, and (iv) a second catheter. The first catheter has a proximal end portion, an opening for removal of cerebrospinal fluid from a subject, and a lumen extending from the proximal end portion to the opening. The first catheter is operably couplable to the reservoir such that fluid is capable of flowing from the lumen to the reservoir. The second catheter has a proximal end portion, a delivery region for returning cerebrospinal fluid to the subject, and a lumen extending from the proximal end portion to the delivery region. The second catheter is operably couplable to the reservoir such that fluid is capable of flowing from the reservoir to the lumen.

Claims

1. A system for removing a target molecule from cerebrospinal fluid of a subject, the system comprising:

a medium having a solid support to which an antibody directed to the target molecule is bound;

a reservoir for containing the medium;

a first catheter including a proximal end portion, an opening, and a lumen extending from the proximal end portion of the first catheter to the opening, wherein the first catheter is operably couplable to the reservoir such that fluid is capable of flowing from the lumen to the reservoir, and wherein the opening is configured to be placed in the cerebrospinal fluid of the subject; and

a second catheter including a proximal end portion, a delivery region and a lumen extending from the proximal end portion of the second catheter to the delivery region, wherein the second catheter is operably couplable to the reservoir such that fluid is capable of flowing from the reservoir to the lumen, and wherein the delivery region is configured to be placed in the cerebrospinal fluid of the subject.

2. The system of claim 1, wherein the target molecule is amyloid beta.

3. The system of claim 1, further comprising:

a pump operably couplable to the first catheter, second catheter, and the reservoir, wherein the pump is configured to cause cerebrospinal fluid to flow from the opening of the first catheter through the reservoir and to the delivery region of the second catheter.

4. The system of claim 1, further comprising a filter positioned and configured to allow cerebrospinal fluid to flow from the reservoir to the lumen of the second catheter and to prevent flow of the medium from the reservoir to the lumen of the second catheter.

5. The system of claim 1, wherein the solid support comprises beads.

6. The system of claim 5, wherein the beads comprise pores having a diametric dimension of between about 300 to about 700 angstroms.

7. The system of claim 1, wherein the medium comprises a membrane and wherein the antibodies are bound to the membrane.

8. The system of claim 1, wherein the medium comprises a fiber and wherein the antibodies are bound to the fiber.

9. The system of claim 1, further comprising a housing, wherein the reservoir is disposed within the housing.

10. The system of claim 9, wherein the housing is hermetically sealed and is configured to be implanted within the subject.

11. The system of claim 10, further comprising a port providing access to the reservoir from outside the housing.

12. The system of claim 1, wherein a single multi-lumen catheter comprises the first and second catheters.

13. A method for removing a target molecule from cerebrospinal fluid of a subject, the method comprising:

withdrawing fluid from a first cerebrospinal fluid compartment of the subject;

passing the withdrawn fluid through a reservoir of a medical device to remove the target molecule from the withdrawn fluid, wherein the reservoir contains a medium comprising a solid support to which an antibody directed to the target molecule is bound and wherein the media is capable of removing the target molecule from the cerebrospinal fluid;

returning the withdrawn fluid with removed target molecule to a second cerebrospinal fluid compartment of the subject,

wherein the first and second cerebrospinal fluid compartments are the same or different.

14. The method of claim 13, wherein the target molecule is amyloid beta.

15. The method of claim 13, further comprising filtering the media from the withdrawn fluid with removed target molecule prior to returning the withdrawn fluid with removed target molecule to the second cerebrospinal fluid compartment of the subject.

16. The method of claim 13, further comprising regenerating the medium to increase the capacity of the medium to remove the target molecule from the withdrawn fluid.

17. The method of claim 13 further comprising removing the medium from the reservoir and placing fresh medium in the reservoir.

18. An implantable medical device comprising:

a housing;

a reservoir disposed in the housing;

a medium disposed in the reservoir and comprising a solid surface to which antibodies directed to a target molecule are bound;

a fluid outlet operably coupled to the reservoir;

a fluid inlet operably coupled to the reservoir; and

a pump disposed in the housing, operably coupled to the fluid inlet, the fluid outlet, and the reservoir, and configured to cause fluid to flow from the inlet through the reservoir and to the outlet.

19. The implantable device of claim 18, wherein the target molecule is amyloid beta.

20. The implantable device of claim 18, further comprising a port providing access to the reservoir from outside the housing.

21. A system comprising:

the implantable medical device of claim 18;

a first catheter including a proximal end portion, an opening, and a lumen extending from the proximal end portion to the opening, wherein the first catheter is operably couplable to the fluid inlet such that fluid is capable of flowing from the lumen to the inlet, and wherein the opening is configured to be placed in the cerebrospinal fluid of the subject; and

a second catheter including a proximal end portion, a delivery region and a lumen extending from the proximal end portion to the delivery region, wherein the second catheter is operably couplable to the fluid outlet such that fluid is capable of flowing from the outlet to the lumen, and wherein the delivery region is configured to be placed in the cerebrospinal fluid of the subject.

22. The system of claim 21, wherein a single multi-lumen catheter comprises the first and second catheters.